75 FR 177 pg. 55803 - Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events, Funding Opportunity Announcement, CI11-001, Initial Review
Type: NOTICEVolume: 75Number: 177Page: 55803
FR document: [FR Doc. 2010-22759 Filed 9-13-10; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and ControlSpecial Emphasis Panel (SEP): Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events, Funding Opportunity Announcement, CI11-001, Initial Review
In accordance with Section 10(a)(2) of the Federal AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl and Prevention (CDC) announces the aforementioned meeting:
Time and Date
8 a.m.-5 p.m., November 8, 2010 (Closed).
Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997-1100.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to "Epi-Centers for the Prevention of Healthcare-Associated Infectious, Antimicrobial Resistance and Adverse Events, FOA CI11-001."
Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498-2293.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease Control and Prevention.
[FR Doc. 2010-22759 Filed 9-13-10; 8:45 am]
BILLING CODE 4163-18-P